Intercell names new CEO


Struggling vaccine developer Intercell AG has presented a new company chief.The Vienna-based research firm said today (Thurs) board member Thomas Lingelbach will take over as CEO next Tuesday (10 May). Current head Gerd Zettlmeissl will leave the company “to pursue other personal and professional interests,” Intercell added.Lingelbach has been the company¬ís COO since 2006. He […]